ZAHARA II Risk Calculator
Maternal Cardiac Risk Assessment
Select each clinical feature present according to the ZAHARA risk model.
These are cohort-derived category event rates, not individualized probabilities calibrated for every cardiac diagnosis. ZAHARA was developed in women with congenital heart disease; applicability to other populations is limited.
About the ZAHARA Risk Score
The ZAHARA score was developed to estimate maternal cardiovascular complications in women with congenital heart disease. It is a weighted clinical score, not the linear-predictor equation present in the uploaded source file.
Predictors and weights
| Predictor | Points |
|---|---|
| History of arrhythmias | 1.50 |
| Cardiac medication before pregnancy | 1.50 |
| NYHA class ≥ II before pregnancy | 0.75 |
| Left heart obstruction | 2.50 |
| Moderate/severe systemic AV valve regurgitation | 0.75 |
| Moderate/severe pulmonary AV valve regurgitation | 0.75 |
| Mechanical valve prosthesis | 4.25 |
| Cyanotic congenital heart disease, corrected or uncorrected | 1.00 |
Reported maternal event rates
| Total score | Reported event rate |
|---|---|
| 0–0.50 | 2.9% |
| 0.51–1.50 | 7.5% |
| 1.51–2.50 | 17.5% |
| 2.51–3.50 | 43.1% |
| >3.50 | 70.0% |
References
Important scope limitation
ZAHARA was derived for congenital heart disease and should not replace contemporary multidisciplinary assessment, lesion-specific risk assessment, or guideline-based pregnancy risk classification. Confirm the intended model name and citation before publishing under the “ZAHARA II” label.
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.